Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$34,367,258
-$4,080,185 QoQ
Shares Held
272,022
-1.4% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#261
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 30%
Shared 1%
None 70%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Sep 30, 2020CallValue
$492,882
CallShares
7,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $2,652,531,465 across 15 Drug Manufacturers - General names. GILD ranks #11 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,519,569 | $634,024,342 | |
| 2 | JNJ |
Johnson & Johnson
|
2,173,861 | $552,095,477 | |
| 3 | LLY |
ELI LILLY & Co
|
400,653 | $480,555,266 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,308,510 | $296,643,534 | |
| 5 | NVS |
Novartis AG
|
968,701 | $151,814,820 | |
| 6 | AZN |
Astrazeneca PLC
|
797,497 | $151,221,380 | |
| 7 | AMGN |
Amgen Inc
|
394,190 | $142,744,081 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,277,343 | $73,600,502 |
All Filings in GILD
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,367,258 | 272,022 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $38,447,443 | 275,866 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $38,042,034 | 309,940 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $34,447,407 | 310,337 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $39,150,745 | 353,123 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $40,357,607 | 360,175 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $34,152,421 | 369,735 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $32,455,301 | 387,110 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $27,917,476 | 406,901 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $32,704,146 | 446,473 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $39,979,810 | 493,517 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $42,973,967 | 573,445 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $43,587,322 | 565,555 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $54,828,898 | 660,828 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $70,702,538 | 823,559 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $56,889,036 | 922,176 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $48,005,415 | 776,661 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $41,526,002 | 698,503 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $52,587,500 | 724,246 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $50,376,657 | 721,212 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $74,157,053 | 1,076,925 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $71,033,345 | 1,099,077 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $60,371,980 | 1,036,251 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $68,834,065 | 1,089,319 | Shares | Defined | 2021-11-05 | |
| 2020-09-30 | $492,882 | 7,800 | Call | Defined | 2021-11-05 | |
| 2020-06-30 | $73,293,887 | 952,611 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $91,685,286 | 1,226,395 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||